Inhibitors of Factor Xa

This publication has 8 references indexed in Scilit:

• Hypersulfated Low Molecular Weight Heparin with Reduced Affinity for Antithrombin Acts as an Anticoagulant by Inhibiting Intrinsic Tenase and Prothrombinase
  Journal of Biological Chemistry, 2001
• Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a Highly Potent, Selective, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa
  Journal of Medicinal Chemistry, 2001
• Low molecular weight heparin in unstable coronary artery disease
  Expert Opinion on Investigational Drugs, 2000
• Procoagulant Expression in Platelets and Defects Leading to Clinical Disorders
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Factor Xa inhibitors
  Expert Opinion on Therapeutic Patents, 1999
• A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin
  FEBS Letters, 1998
• Structural basis for chemical inhibition of human blood coagulation factor Xa
  Proceedings of the National Academy of Sciences, 1998
• Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin
  Clinical and Experimental Immunology, 1997